Search

Your search keyword '"Hasslacher, Christoph"' showing total 5 results
Start Over Author "Hasslacher, Christoph" Database OpenAIRE
5 results on '"Hasslacher, Christoph"'

1. Additional file 3 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Author

Kerstan, Andreas, Dieter, Kathrin, Niebergall-Roth, Elke, Klingele, Sabrina, Jünger, Michael, Hasslacher, Christoph, Daeschlein, Georg, Stemler, Lutz, Meyer-Pannwitt, Ulrich, Schubert, Kristin, Klausmann, Gerhard, Raab, Titus, Goebeler, Matthias, Kraft, Korinna, Esterlechner, Jasmina, Schröder, Hannes M., Sadeghi, Samar, Ballikaya, Seda, Gasser, Martin, Waaga-Gasser, Ana M., Murphy, George F., Orgill, Dennis P., Frank, Natasha Y., Ganss, Christoph, Scharffetter-Kochanek, Karin, Frank, Markus H., and Kluth, Mark A.

Abstract

Additional file 3. Figure S1. Validation of the rabbit anti-human/mouse CD31 antibody. Figure S2. Blood flow recovery following surgically indcued hindlimb ischemia in OF1 mice.

Published
2022
Full Text
View/download PDF

2. Additional file 2 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Author

Kerstan, Andreas, Dieter, Kathrin, Niebergall-Roth, Elke, Klingele, Sabrina, Jünger, Michael, Hasslacher, Christoph, Daeschlein, Georg, Stemler, Lutz, Meyer-Pannwitt, Ulrich, Schubert, Kristin, Klausmann, Gerhard, Raab, Titus, Goebeler, Matthias, Kraft, Korinna, Esterlechner, Jasmina, Schröder, Hannes M., Sadeghi, Samar, Ballikaya, Seda, Gasser, Martin, Waaga-Gasser, Ana M., Murphy, George F., Orgill, Dennis P., Frank, Natasha Y., Ganss, Christoph, Scharffetter-Kochanek, Karin, Frank, Markus H., and Kluth, Mark A.

Abstract

Additional file 2. Methods S1. Determination of the wound surface area.

Published
2022
Full Text
View/download PDF

3. Additional file 1 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Author

Kerstan, Andreas, Dieter, Kathrin, Niebergall-Roth, Elke, Klingele, Sabrina, Jünger, Michael, Hasslacher, Christoph, Daeschlein, Georg, Stemler, Lutz, Meyer-Pannwitt, Ulrich, Schubert, Kristin, Klausmann, Gerhard, Raab, Titus, Goebeler, Matthias, Kraft, Korinna, Esterlechner, Jasmina, Schröder, Hannes M., Sadeghi, Samar, Ballikaya, Seda, Gasser, Martin, Waaga-Gasser, Ana M., Murphy, George F., Orgill, Dennis P., Frank, Natasha Y., Ganss, Christoph, Scharffetter-Kochanek, Karin, Frank, Markus H., and Kluth, Mark A.

Abstract

Additional file 1. Table S1. Reported healing failure rates of diabetic foot ulcers. Table S2. Antibodies used for immunofluorescence evaluation. Table S3. Primers. Table S4. ABCB5+ MSC product release data. Table S5. LDPI measurements. Table S6. CD31 expression in the ischemic thigh muscle of OF1 mice with surgically induced hindlimb ischemia treated with vehicle or ABCB5+ MSCs. Table S7. Absolute wound surface area reduction from baseline by visit. Table S8. Patients with complete wound closure and with ≥30% wound surface area reduction by visit. Table S9. Wound exudation by visit. Table S10. Pain score by visit. Table S11. Quality of life scores by visit. Table S12. Serious treatment-emergent adverse events. Table S13. Vital signs. Table S14. Changes in physical examination findings from screening visit. Table S15. Controlled clinical trials evaluating the efficacy of cell-based adjunctive strategies to treat diabetic foot ulcers.

Published
2022
Full Text
View/download PDF

4. DAVIES_AUTOMATIX_Supplementary_Material – Supplemental material for A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes

Author

Davies, Melanie, Bain, Steve, Charpentier, Guillaume, Flacke, Frank, Goyeau, Harmonie, Woloschak, Michael, Hasslacher, Christoph, Vespasiani, Giacomo, and Edelman, Steven

Subjects
111708 Health and Community Services, FOS: Clinical medicine, 111199 Nutrition and Dietetics not elsewhere classified, Medicine, FOS: Health sciences, 110306 Endocrinology
Abstract

Supplemental material, DAVIES_AUTOMATIX_Supplementary_Material for A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes by Melanie Davies, Steve Bain, Guillaume Charpentier, Frank Flacke, Harmonie Goyeau, Michael Woloschak, Christoph Hasslacher, Giacomo Vespasiani and Steven Edelman in Journal of Diabetes Science and Technology

Published
2019
Full Text
View/download PDF

5. Subkonjunktivaler Biochip zur fotometrischen Blutzuckermessung

Author

Auffarth, Gerd U., Hasslacher, Christoph, Ehmer, Angela, Mutzek, Julia, Mannsfeld, Annett, Limberger, Il-Joo, and Rabsilber, Tanja M.

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Zielsetzung: Laborexperimentelle und klinische Evaluierung eines subkonjunktivalen Biochips zur Blutzuckermessung bei Diabetes mellitus Patienten. Methode: In 16 Augen von 16 Patienten mit einem mittleren Alter von 50,0+/-14,6 Jahren (22 bis 65 Jahre) wurde ein Hydrogel Biochip unter die[for full text, please go to the a.m. URL], 22. Internationaler Kongress der Deutschen Ophthalmochirurgen

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results